Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
File(s)Hearing loss letter final July21 2017.docx (26.45 KB)
Accepted version
Author(s)
Cox, H
Reuter, A
Furin, J
Seddon, J
Type
Journal Article
Abstract
In their Lancet Review, Blake S Wilson and colleagues (July 10)1 describe the growing global burden of hearing loss caused by a range of possible factors. The use of ototoxic medication is a considerable contributor to hearing loss for both children and adults. The authors suggest a primary prevention strategy for reducing hearing loss, which includes the use of ototoxic drugs only when no alternatives are available and only for serious conditions.
Date Issued
2017-09-02
Date Acceptance
2017-07-26
Citation
Lancet, 2017, 390 (10098), pp.934-934
ISSN
0140-6736
Publisher
Elsevier
Start Page
934
End Page
934
Journal / Book Title
Lancet
Volume
390
Issue
10098
Copyright Statement
© 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
PII: S0140-6736(17)32170-0
Subjects
11 Medical And Health Sciences
General & Internal Medicine
Publication Status
Published